# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 25일


## 주요 헤드라인

1. **J&J’s Anti-Tau Bet Falls Flat in Mid-Stage Alzheimer’s Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-js-anti-tau-bet-falls-flat-in-mid-stage-alzheimers-trial>

2. **J&J’s Anti-Tau Bet Falls Flat in Mid-Stage Alzheimer’s Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-js-anti-tau-bet-falls-flat-in-mid-stage-alzheimers-trial>

3. **Biogen’s Leqembi Rises After Novo GLP-1 Fails in Alzheimer’s (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/biogens-leqembi-rises-after-novo-glp-1-fails-in-alzheimers>

4. **Biogen’s Leqembi Rises After Novo GLP-1 Fails in Alzheimer’s (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/biogens-leqembi-rises-after-novo-glp-1-fails-in-alzheimers>

5. **Novo’s GLP-1 Fails to Slow Alzheimer’s, Sending Shares Down 10% (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novos-glp-1-fails-to-slow-alzheimers-sending-shares-down-10>

6. **Novo’s GLP-1 Fails to Slow Alzheimer’s, Sending Shares Down 10% (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novos-glp-1-fails-to-slow-alzheimers-sending-shares-down-10>

7. **NervGen’s Peptide Achieves Nervous System Repair in Phase II Spinal Cord Injury Study (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/nervgens-peptide-achieves-nervous-system-repair-in-phase-ii-spinal-cord-injury-study>


---
*2025년 11월 25일 바이오스페이스 뉴스 피드에서 생성된 리포트*